• 제목/요약/키워드: multidrug-resistant bacteria

검색결과 99건 처리시간 0.031초

Antibiotic Reversal Activity of Piper longum Fruit Extracts against Staphylococcus aureus Multi-Drug Resistant Phenotype

  • Maryam Salah Ud Din;Umar Farooq Gohar;Hamid Mukhtar;Ibrar Khan;John Morris;Soisuda Pornpukdeewattana;Salvatore Massa
    • 한국미생물·생명공학회지
    • /
    • 제51권4호
    • /
    • pp.432-440
    • /
    • 2023
  • Irrational and injudicious use of antibiotics, easy availability of them as over-the-counter drugs in economically developing countries, and unavailability of regulatory policies governing antimicrobial use in agriculture, animals, and humans, has led to the development of multi-drug resistance (MDR) bacteria. The use of medicinal plants can be considered as an alternative, with a consequent impact on microbial resistance. We tested extracts of Piper longum fruits as new natural products as agents for reversing the resistance to antibiotics. Six crude extracts of P. longum fruits were utilized against a clinical isolate of multidrug-resistant Staphylococcus aureus.The antibiotic susceptibility testing disc method was used in the antibiotic resistance reversal analysis. Apart from cefoxitin and erythromycin, all other antibiotics used (lincosamides [clindamycin], quinolones [levofloxacin and ciprofloxacin], and aminoglycosides [amikacin and gentamicin]) were enhanced by P. longum extracts. The extracts that showed the greatest synergy with the antibiotics were EAPL (ethyl acetate [extract of] P. longum), n-BPL (n-butanol [extract of] P. longum), and MPL (methanolic [extract of] P. longum The results of this study suggest that P. longum extracts have the ability to increase the effectiveness of different classes of antibiotics and reverse their resistance. However, future studies are needed to elucidate the molecular mechanisms behind the synergy between antibiotic and phytocompound(s) and identify the active biomolecules of P. longum responsible for the synergy in S. aureus.

Homology Modeling and Docking Study of β-Ketoacyl Acyl Carrier Protein Synthase Ⅲ from Enterococcus Faecalis

  • Jeong, Ki-Woong;Lee, Jee-Young;Kim, Yang-Mee
    • Bulletin of the Korean Chemical Society
    • /
    • 제28권8호
    • /
    • pp.1335-1340
    • /
    • 2007
  • β-Ketoacyl acyl carrier protein synthase (KAS) III is a particularly attractive target in the type II fatty acid synthetic pathway, since it is central to the initiation of fatty acid synthesis. Enterococcus faecalis, a Grampositive bacterium, is one of the major causes of hospital acquired infections. The rise of multidrug-resistant of most bacteria requires the development of new antibiotics, such as inhibition of the KAS III. In order to block the fatty acid synthesis by inhibition of KAS III, at first, three dimensional structure of Enterococcus faecalis KAS III (efKAS III) was determined by comparative homology modeling using MODELLER based on x-ray structure of Staphylococcus aureus KAS III (saKAS III) which is a gram-positive bacteria and is 36.1% identical in amino acid sequences with efKAS III. Since His-Asn-Cys catalytic triad is conserved in efKAS III and saKAS III, substrate specificity of efKAS III and saKAS III and the size of primer binding pocket of these two proteins are expected to be similar. Ligand docking study of efKAS III with naringenin and apigenin showed that naringenin docked more strongly with efKAS III than apigenin, resulting in the intensive hydrogen bond network between naringenin and efKAS III. Also, only naringenin showed antibacterial activity against E. faecalis at 256 μg/mL. This study may give practical implications of flavonoids for antimicrobial effects against E. faecalis.

근관감염균에 대한 polyphosphate의 항균효과 (ANTIBACTERIAL EFFECT OF POLYPHOSPHATE ON ENDODONTOPATHIC BACTERIA)

  • 신정희;박상진;최기운
    • Restorative Dentistry and Endodontics
    • /
    • 제28권6호
    • /
    • pp.435-448
    • /
    • 2003
  • This study was performed to observe the antibacterial effect of polyphosphate (polyP) with various chain lengths (P3~P75) on virulent. invasive strains of P. gingivalis A7A1-28 and W50, and multidrug resistant E. faecalis ATCC29212. P. gingivalis strains were grown in brain-heart infusion broth (BHI) containing hemin and vitamin K with or without polyP. PolyP was added at the very beginning of the culture or during the exponential growth phase of the culture. Inhibition of the growth of P. gingivalis was determined by measuring the absorbancy at 540nm of the grown cells. Viable cell counts of the culture and release of intracellular nucleotide from P. gingivalis were measured. E. faecalis was grown in plain BHI with antibiotics alone or in combination with polyP(calgon: 0.1~1.0%) and the bacterial absorbancy was measured. The overall results suggest that polyP has a strong antibacterial effect on the growth of the virulent strains of P. gingivalis and the antibacterial activity of polyP seems largely bactericidal. accompanying bacteriolysis in which chelation phenomenon is not involved. Although polyP does not exert antibacterial activity against E. faecalis, it appears to increase antibacterial effect of erythromycin and tetracycline on the bacterium. Therefore, polyP alone or in combination with antibiotics may be developed as a candidate for the agent controlling oral infections including endodontic infection.

Antibacterial Efficacies of Disinfectants against Salmonella typhimurium Depending on Pre-warming Conditions

  • Lee, Jin-Ju;Kim, Dong-Hyeok;Kim, Dae-Geun;Simborio, Hannah Leah;Min, Won-Gi;Lee, Hu-Jang;Chang, Dong-Il;Chang, Hong-Hee;Kim, Suk
    • 농업생명과학연구
    • /
    • 제46권5호
    • /
    • pp.65-72
    • /
    • 2012
  • Salmonellosis is a widespread bacterial zoonosis that commonly causes enterocolitis and foodborne poisoning leading to an extensive economic loss in domestic animal industry. Considerably, the emergence of multidrug resistant strains of Salmonella spp. induces further severe problems affecting public health. The present report was designated to investigate the antibacterial efficacies of three common disinfectants including an oxidizing compound disinfectant (OXC), a triple salt (TS) and a quaternary ammonium compound (QAC) against Salmonella typhimurium subjected to the preliminary changes of drug temperature. All solutions of three disinfectants were pre-incubated at different temperature (22, 37 and $63^{\circ}C$) for 1 h prior to exposure to bacteria. The disinfectants and bacteria were diluted with distilled water (DW), hard water (HW) or organic matter suspension (OMS) according to treatment condition. Under the DW condition, the disinfectant efficacy of the QAC at $63^{\circ}C$ was higher than that of $22^{\circ}C$. Furthermore, under HW diluent the disinfectant efficacy of the TS pre-warmed at both of 37 and $63^{\circ}C$ were increased compared to that of $22^{\circ}C$. Considerably, the efficacy of pre-warmed QAC at both of 37 and $63^{\circ}C$ under the OMS diluent were higher than that of $22^{\circ}C$. Conclusively, prewarming at higher temperatures have positive effects on the stability of the antibacterial efficacies of TS and QAC.

Riboflavin Inhibits Growth of Helicobacter pylori by Down-regulation of polA and dnaB Genes

  • Kwon, Hye Jin;Lee, Min Ho;Kim, Hyun Woo;Yang, Ji Yeong;Woo, Hyun Jun;Park, Min;Moon, Cheol;Kim, Sa-Hyun;Kim, Jong-Bae
    • 대한의생명과학회지
    • /
    • 제26권4호
    • /
    • pp.288-295
    • /
    • 2020
  • Infection of Helicobacter pylori on gastric mucosa is associated with various gastric diseases. According to the WHO, H. pylori causes gastric cancer and has been classified as a class I carcinogen. Riboflavin is an essential vitamin which presents in a wide variety of foods. Previous studies have shown that riboflavin/UVA was effective against the growth inhibition of Staphylococcus aureus, S. epidermidis and multidrug-resistant Pseudomonas aeruginosa and had the potential for antimicrobial properties. Thus, we hypothesized that riboflavin has a potential role in the growth inhibition of H. pylori. To demonstrate inhibitory concentration of riboflavin against H. pylori, we performed agar and broth dilution methods. As a result, we found that riboflavin inhibited the growth of H. pylori. The MIC was 1 mM in agar and broth dilution test. Furthermore, to explain the inhibitory mechanism, we investigated whether riboflavin has an influence on the replication-associated molecules of the bacteria using RT-PCR to detect mRNA expression level in H. pylori. Riboflavin treatment of H. pylori led to down-regulation of polA and dnaB mRNA expression levels in a dose dependent manner. After then, we also confirmed whether riboflavin has cytotoxicity to human cells. We used AGS, a gastric cancer cell line, and treated with riboflavin did not show statistically significant decrease of cell viability. Thus, these results indicate that riboflavin can suppress the replication machinery of H. pylori. Taken together, these findings demonstrate that riboflavin inhibits growth of H. pylori by inhibiting replication of the bacteria.

충청지역에서 분리된 사람 유래 대장균 및 닭 유래 대장균의 항균제 내성 및 MLST를 이용한 유전형의 분포 조사 (Molecular Characterization of Escherichia coli Isolates from Humans and Chickens in the Chungcheong Area Using MLST Analysis)

  • 김세미;성지연;최승구
    • 대한임상검사과학회지
    • /
    • 제47권2호
    • /
    • pp.71-77
    • /
    • 2015
  • 최근 항균제의 광범위한 사용으로 인한 항균제 내성세균의 출현과 확산이 축산환경에서 빈번하게 일어나고 있고 이렇게 출현한 다제 내성세균은 사람에게 직접 전파될 수 있어 큰 문제가 되고 있다. 본 연구는 2013년 7월부터 2014년 7월까지 충청지역의 임상검체(n=44) 및 양계농장의 닭(n=34)에서 분리된 78주의 대장균을 대상으로 이루어졌다. PCR과 염기서열 분석을 통하여 MLST 분석과 class 1 integron의 유전형을 분석하였다. 항균제 감수성 검사는 디스크 확산법으로 시행하였다. 사람 유래 대장균의 경우 ST131 (n=20)과 ST38 (n=15)이 가장 많았고 닭 유래 대장균은 ST752 (n=7)이 가장 많았으며 ST117, ST189, ST69는 각각 4주였다. 사람에서 유래한 대장균은 총 44주 중 25주가 class 1 integron을 가지고 있었다. 반면 닭에서 유래한 대장균은 총 34주 중 11주가 class 1 integron을 가지고 있었다. 충청지역에 분포되어있는 사람 유래 대장균과 닭 유래 대장균의 유전형 및 항균제 내성 패턴에 차이를 보였다.

대중음식점 일회용 물티슈의 세균 오염도 조사(2) (Bacterial Contamination in Disposable Wet Wipes in General Restaurants 2nd)

  • 정무상
    • 대한임상검사과학회지
    • /
    • 제54권1호
    • /
    • pp.23-27
    • /
    • 2022
  • 제주특별자치도에 위치한 대중음식점에서 제공하는 일회용 물티슈를 대상으로 식품의약품안전처장이 정하는 표시사항을 준수하는지 여부와 세균의 오염도를 평가하였다. 일회용 물티슈 32종류 중 5 종류의 일회용 물티슈는 영업소의 명칭 및 소재지가 표기되어 있지 않았다. 제조연월일과 유통기한은 12 종류의 물티슈만 표시 되어있었다. 일회용 물티슈 32종류 중 9종류의 물티슈에서 세균 집락이 배양되었으며, 23종류(71.9%)의 물티슈에서는 세균이 배양되지 않았다. 세균을 동정한 결과 그람양성알균은 Staphylococcus haemolyticus 4균주, Staphylococcus hominis 1균주, Staphylococcus warneri 3균주, 그람음성막대균은 Pseudomonas fluorescens 1균주로 동정되었다. 동정된 그람양성알균 8균주에 대한 항균제감수성검사를 시행한 결과 oxacillin, vancomycin 감수성으로 MRCNS(methicillin resistant coagulase-negative Staphylococci)는 발견되지 않았으며, 동정된 그람음성막대균 1균주에 대한 항균제감수성검사 결과는 imipenem, meropenem에 모두 감수성으로 다약제내성균은 아니었다. 본 연구를 통해 위생용품으로 지정된 일회용 물티슈 개별 포장지 겉면에 반드시 제조년월일과 유통기한을 표기하고, 보관기준을 준수하여 오염되지 않은 깨끗한 물티슈를 사용해야 한다고 사료된다. 또한 위생관리 감독 강화와 개선방안 및 개인 위생관리 및 국민보건 수준향상에 기여하고자 한다.

블렌딩 에센션오일의 항균효과 증진 (Improved Antibacterial Effect of Blending Essential Oils)

  • 권필승;김대중;박호
    • 대한임상검사과학회지
    • /
    • 제49권3호
    • /
    • pp.256-262
    • /
    • 2017
  • 식물로부터 유래되는 휘발성 유기 화합물인 에센셜 오일은 인체에 약리효과를 나타낸다고 알려져 있다. 본 연구에서는 화농성 질환과 병독성 질환 비뇨기계통 감염에 나올 수 있는 병원성 세균 Staphylococcus aureus (그람양성알균), Escherichia coli (그람음성막대균), Pseudomonas aeruginosa (그람음성막대균, 극성단모균)을 대상으로 천연 허브 오일 중에 비교적 많이 알려져 있는 라벤더(lavender), 티트리(tea tree), 로즈마리(rosemary), 멜리사(melisa) 4종류의 단일 오일과 비교해, 티트리와 로즈마리, 멜리사를 블렌딩하였을 때 항균력이 상승되는 효과가 있는지 연구하였다. 그 결과 디스크 확산법에서 블렌딩 오일(티트리, 로즈마리, 멜리사)의 경우 단독의 허브오일보다 S. aureus에서18 mm, E. coli 에서 22 mm 와 P. aeruginosa는13 mm의 우수한 항균능력을 확인할 수 있었다. 뿐만 아니라 블렌딩 오일의 경우 최소억제농도(Minimum Inhibitory Concentrations, MIC) 분석에서 S. aureus, E. coli 에서는 0.3125%에서, P. aeruginosa는 1.25%에서 성장억제효과가 확인되었다. 따라서 본 실험에서는 블렌딩 오일이 Oxacillin과 로즈마리, 티트리보다 항균효과가 우수한 것으로 증명되어 단독의 허브오일보다 블렌딩 오일이 우수한 항균력을 나타나는 것을 확인할 수 있었다. 그러므로 허브의 블렌딩을 활용하면 다제 내성균에 대한 항균시너지효과를 발휘할 수 있음을 입증했을 뿐만 아니라 향후 천연보존제와 건강기능성 식품 및 화장품에 활용 가능성을 기대해본다.

Green Synthesis of Silver Nanoparticles Using Cell Extracts of Anabaena doliolum and Screening of Its Antibacterial and Antitumor Activity

  • Singh, Garvita;Babele, Piyoosh K.;Shahi, Shailesh K.;Sinha, Rajeshwar P.;Tyagi, Madhu B.;Kumar, Ashok
    • Journal of Microbiology and Biotechnology
    • /
    • 제24권10호
    • /
    • pp.1354-1367
    • /
    • 2014
  • In the present work, we describe a simple, cheap, and unexplored method for "green" synthesis of silver nanoparticles using cell extracts of the cyanobacterium Anabaena doliolum. An attempt was also made to test the antimicrobial and antitumor activities of the synthesized nanoparticles. Analytical techniques, namely UV-vis spectroscopy, X-ray diffraction, Fourier transform infrared (FTIR) spectroscopy, transmission electron microscopy (TEM), and TEM-selected area electron diffraction, were used to elucidate the formation and characterization of silver-cyanobacterial nanoparticles (Ag-CNPs). Results showed that the original color of the cell extract changed from reddish blue to dark brown after addition of silver nitrate solution (1 mM) within 1 h, suggesting the synthesis of Ag-CNPs. That the formation Ag-CNPs indeed occurred was also evident from the spectroscopic analysis of the reaction mixture, wherein a prominent peak at 420 nm was noted. TEM images revealed well-dispersed, spherical Ag-CNPs with a particle size in the range of 10-50 nm. The X-ray diffraction spectrum suggested a crystalline nature of the Ag-CNPs. FTIR analysis indicated the utilization of a hydroxyl (-OH) group in the formation of Ag-CNPs. Ag-CNPs exhibited strong antibacterial activity against three multidrug-resistant bacteria. Additionally, Ag-CNPs strongly affected the survival of Dalton's lymphoma and human carcinoma colo205 cells at a very low concentration. The Ag-CNPs-induced loss of survival of both cell types may be due to the induction of reactive oxygen species generation and DNA fragmentation, resulting in apoptosis. Properties exhibited by the Ag-CNP suggest that it may be used as a potential antibacterial and antitumor agent.

No more tears from surgical site infections in interventional pain management

  • Seungjin Lim;Yeong-Min Yoo;Kyung-Hoon Kim
    • The Korean Journal of Pain
    • /
    • 제36권1호
    • /
    • pp.11-50
    • /
    • 2023
  • As the field of interventional pain management (IPM) grows, the risk of surgical site infections (SSIs) is increasing. SSI is defined as an infection of the incision or organ/space that occurs within one month after operation or three months after implantation. It is also common to find patients with suspected infection in an outpatient clinic. The most frequent IPM procedures are performed in the spine. Even though primary pyogenic spondylodiscitis via hematogenous spread is the most common type among spinal infections, secondary spinal infections from direct inoculation should be monitored after IPM procedures. Various preventive guidelines for SSI have been published. Cefazolin, followed by vancomycin, is the most commonly used surgical antibiotic prophylaxis in IPM. Diagnosis of SSI is confirmed by purulent discharge, isolation of causative organisms, pain/tenderness, swelling, redness, or heat, or diagnosis by a surgeon or attending physician. Inflammatory markers include traditional (C-reactive protein, erythrocyte sedimentation rate, and white blood cell count) and novel (procalcitonin, serum amyloid A, and presepsin) markers. Empirical antibiotic therapy is defined as the initial administration of antibiotics within at least 24 hours prior to the results of blood culture and antibiotic susceptibility testing. Definitive antibiotic therapy is initiated based on the above culture and testing. Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria infections appears to be superior to monotherapy in mortality with the risk of increasing antibiotic resistance rates. The never-ending war between bacterial resistance and new antibiotics is continuing. This article reviews prevention, diagnosis, and treatment of infection in pain medicine.